Bill Seeks to Regulate ‘Biosimilar’ Drugs

Two of the nation’s largest biotech companies, Amgen Inc. and Genentech Inc., are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs, the Los Angeles Times reports. Opponents say SB 598 bill would establish roadblocks to keep cheaper substitutes off the market in the state.